All Articles

Browse all articles — filter by topic, how strong the science is, or date.

Showing 625–648 of 767 in Treatments & Drugs

Apr 9, 2026investor.lilly.com

"Could a new pill help you lose weight safely?"

landmarkTreatments & Drugslarge human trial

Apr 9, 2026globenewswire.com

Sobi reçoit l’autorisation par Santé Canada pour EMPAVELIMD (pegcétacoplan) dans le traitement de la GC3 et de la GNMP-CI primitive.

generalTreatments & Drugs

Apr 9, 2026globenewswire.com

Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting

generalTreatments & Drugs

Apr 9, 2026lifespan.io

A Combination NAD+ Treatment Has Benefits for Mice

significantTreatments & Drugs

Apr 9, 2026globenewswire.com

Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting

generalTreatments & Drugs

Apr 9, 2026globenewswire.com

InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor

generalTreatments & Drugs

Apr 9, 2026globenewswire.com

Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026

generalTreatments & Drugs

Apr 9, 2026globenewswire.com

Soleo Health Opens New Ambulatory Infusion Center in Austin, Texas

generalTreatments & Drugs

Apr 9, 2026investor.lilly.com

"Could a new pill help you lose weight safely?"

significantTreatments & Drugslarge human trial

Apr 9, 2026investor.lilly.com

Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.

significantTreatments & Drugs

Apr 9, 2026globenewswire.com

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Biliary Tract Cancer Following Positive Safety and Preliminary Efficacy Results

generalTreatments & Drugs

Apr 9, 2026globenewswire.com

Kainova Therapeutics Expands Phase I/II Trial of DT-7012, a Treg-depleting Anti-CCR8 Antibody, with First Patient Dosed in Europe

generalTreatments & Drugs

Apr 9, 2026sciencedaily.com

The hidden tradeoff behind today’s most popular weight loss drugs

significantTreatments & Drugs

Apr 9, 2026sciencedaily.com

Breakthrough water filter removes 98% of toxic PFAS forever chemicals

significantTreatments & Drugs

Apr 9, 2026academic.oup.com

Barriers and facilitators to recruiting older adult care home residents into clinical trials of medicines and vaccines: a scoping review

significantTreatments & Drugs

Apr 9, 2026globenewswire.com

HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2026

generalTreatments & Drugs

Apr 8, 2026globenewswire.com

New 23andMe Research Institute Study Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects

generalTreatments & Drugs

Apr 8, 2026globenewswire.com

ROOT Brands® Addresses the GLP-1 Gap with CRUSH and SCULPT, a Science-Driven Protocol for Metabolic and Muscle Support After Ozempic® and Wegovy®

generalTreatments & Drugs

Apr 8, 2026globenewswire.com

Tekton Research Opens First Multi-Specialty Clinical Research Hub in San Antonio

generalTreatments & Drugs

Apr 8, 2026globenewswire.com

Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists

generalTreatments & Drugs

Apr 8, 2026globenewswire.com

CorTec Receives FDA Breakthrough Device Designation for Its Brain Interchange System in Stroke Rehabilitation — the First BCI Worldwide Designated for Stroke Motor Rehabilitation

generalTreatments & Drugs

Apr 8, 2026globenewswire.com

Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis

generalTreatments & Drugs

Apr 8, 2026globenewswire.com

OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

generalTreatments & Drugs

Apr 8, 2026globenewswire.com

Global Infusion Pumps and Devices Market to Reach $14.2 Billion by 2030 as Chronic Disease Burden, Aging Populations and Smart Pump Innovation Drive Growth

generalTreatments & Drugs